 WARMER, Pa., Aug. 05, 2020 GLOBE NEWSWIRE -- Arbutus Biopharma Corporation Nasdaq: ABUS, a clinical-stage biopharmaceutical company primarily focused on developing a cure for people with chronic hepatitis B virus HBV infection, as well as therapies to treat coronaviruses including COVID-19, today announced that William Collier, Arbutus President and Chief Executive Officer, will present at the Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 12, 2020 at 3:30 PM ET. A live webcast of the presentation can be accessed through the Investors section of Arbutus website at or directly at Live Webcast. An archived replay of the webcast will be available on the Companys website after the conference.About ArbutusArbutus Biopharma Corporation is a publicly traded Nasdaq: ABUS biopharmaceutical company dedicated to discovering, developing and commercializing a cure for people with chronic hepatitis B virus HBV infection. The Company is advancing multiple drug product candidates that may be combined into a potentially curative regimen for chronic HBV infection. Arbutus has also initiated a drug discovery and development effort for treating coronaviruses including COVID-19. For more information, visit Information Investors and MediaWilliam H. Collier President and CEO Phone: 267-469-0914 Email: Pam Murphy Investor Relations Consultant Phone: 267-469-0914 Email: 